Impact of cannabinoids on synapse markers in an SH-SY5Y cell culture model

• Published in: NPJ schizophrenia Vol. 10; no. 1; pp. 96 - 19
• Main Authors: Jahn, Kirsten, Blumer, Nina, Wieltsch, Caroline, Duzzi, Laura, Fuchs, Heiko, Meister, Roland, Groh, Adrian, Schulze Westhoff, Martin, Krüger, Tillmann Horst Christoph, Bleich, Stefan, Khan, Abdul Qayyum, Frieling, Helge
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 25-10-2024; Nature Publishing Group; Nature Portfolio
• Subjects: 631/378/340; 631/378/87; Cell culture; Cognitive Psychology; Medicine; Medicine & Public Health; Morphology; Neurology; Neurosciences; Psychiatry; Psychosis
• DOI: 10.1038/s41537-024-00498-6
• EISSN: 2754-6993; 2334-265X
• ISSN: 2754-6993

Patients suffering from schizophrenic psychosis show reduced synaptic connectivity compared to healthy individuals, and often, the use of cannabis precedes the onset of schizophrenic psychosis. Therefore, we investigated if different types of cannabinoids impact methylation patterns and expression of schizophrenia candidate genes concerned with the development and preservation of synapses and synaptic function in a SH-SY5Y cell culture model. For this purpose, SH-SY5Y cells were differentiated into a neuron-like cell type as previously described. Effects of the cannabinoids delta-9-THC, HU-210, and Anandamide were investigated by analysis of cell morphology and measurement of neurite/dendrite lengths as well as determination of methylation pattern, expression (real time-qPCR, western blot) and localization (immunocytochemistry) of different target molecules concerned with the formation of synapses. Regarding the global impression of morphology, cells, and neurites appeared to be a bit more blunted/roundish and to have more structures that could be described a bit boldly as resembling transport vesicles under the application of the three cannabinoids in comparison to a sole application of retinoic acid (RA). However, there were no obvious differences between the three cannabinoids. Concerning dendrites or branch lengths, there was a significant difference with longer dendrites and branches in RA-treated cells than in undifferentiated control cells (as shown previously), but there were no differences between cannabinoid treatment and exclusive RA application. Methylation rates in the promoter regions of synapse candidate genes in cannabinoid-treated cells were in between those of differentiated cells and untreated controls, even though findings were significant only in some of the investigated genes. In other targets, the methylation rates of cannabinoid-treated cells did not only approach those of undifferentiated cells but were also valued even beyond. mRNA levels also showed the same tendency of values approaching those of undifferentiated controls under the application of the three cannabinoids for most investigated targets except for the structural molecules (NEFH, MAPT). Likewise, the quantification of expression via western blot analysis revealed a higher expression of targets in RA-treated cells compared to undifferentiated controls and, again, lower expression under the additional application of THC in trend. In line with our earlier findings, the application of RA led to higher fluorescence intensity and/or a differential signal distribution in the cell in most of the investigated targets in ICC. Under treatment with THC, fluorescence intensity decreased, or the signal distribution became similar to the dispersion in the undifferentiated control condition. Our findings point to a decline of neuronal differentiation markers in our in vitro cell-culture system under the application of cannabinoids.